Study on BPC-157 has been on-going since 1991 and results thereof suggest that the peptide has the capacity to repair damaged bones, muscular tissues, ligaments, as well as even intestinal tracts. This data is based on in-vitro lab tests as well as in-vivo researches performed on both rats and also humans. A few of the human trials involved infusing the peptide under the skin (subcutaneously) as well as right into the muscular tissues (intramuscularly). Learn More

Cambridge Clinical Trials, Medical Trials, Medical research

Clinical Trials for Surgically Sterlised Women